Recalled Paracetamol, a question for CMC gurus [Off Topic]

posted by nobody – 2019-06-28 13:51 (1704 d 05:20 ago) – Posting: # 20365
Views: 5,247


The FDA found termites, dead pests, impurities and other serious GMP violations at Bristol-Myers Squibb’s drug facility in Manati, Puerto Rico, during a Jan. 15-Feb. 6 inspection.

The agency investigators discovered that a media fill conducted at the facility resulted in a vial that was murky and contaminated with bacteria. The firm identified the contaminants as mites. As a result, lots of lyophilized drug products were placed on hold.

Kindest regards, nobody

Complete thread:

UA Flag
 Admin contact
22,912 posts in 4,806 threads, 1,635 registered users;
30 visitors (0 registered, 30 guests [including 6 identified bots]).
Forum time: 18:11 CET (Europe/Vienna)

[…] an inappropriate study design is incapable of answering
a research question, no matter how careful the subsequent
methodology, conduct, analysis, and interpretation:
Flawless execution of a flawed design achieves nothing worthwhile.    J. Rick Turner

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz